# Palvella Therapeutics, Inc.: Form 8-K, filed Dec 12, 2024

- Company: [Palvella Therapeutics, Inc.](/companies/pvla.md) (CIK 1583648)
- Form: 8-K
- Filed: 2024-12-12
- Accepted by EDGAR: Dec 12, 2024, 16:15 ET
- Period: 2024-12-11
- Accession: 0001437749-24-037350
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1583648/000143774924037350/pirs20241115c_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1583648/000143774924037350/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1583648/000143774924037350/pirs20241115c_8k.htm

Filed Dec 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-037350. Last ingested by Listed: Nov 5, 2026, 12:13 ET. No prices; not investment advice.